首页 | 本学科首页   官方微博 | 高级检索  
检索        


Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant
Authors:Simon Cronin  Zaid Al‐Kadhimi  Muneer H Abidi  Lois Ayash  Kendra Mellert  Lawrence G Lum  Voravit Ratanatharathorn  Joseph P Uberti  Abhinav Deol
Institution:1. Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan;2. Department of Hematology and Medical Oncology, Emory University and Winship Cancer Center, Atlanta, Georgia;3. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan;4. Department of Internal Medicine, Wayne State University, Detroit, Michigan;5. Department of Immunology and Microbiology, Wayne State University, Detroit, Michigan
Abstract:We report our experience of collecting stem cells in patients who failed to mobilize sufficient hematopoietic stem cell (HSC) using plerixafor (P) in the initial mobilization attempt. Twenty four patients were identified who failed a first mobilization attempt using P. Of these, 22 patients received granulocyte colony stimulating factor (G‐CSF) and two patients received cyclophosphamide (CY) + G‐CSF in combination with P for the initial attempt. The agents used for second collection attempt were granulocyte macrophage colony stimulating factor (GM‐CSF) + G‐CSF (19 patients), G‐CSF + P (three patients), CY + G‐CSF (one patient), and bone marrow harvest (one patient). A median of 0.6 × 106 CD34+ cells/kg (range 0–1.97) were collected in the initial attempt. A second collection was attempted at a median of 22 days (range 15–127) after the first failed mobilization. The median CD34+ cell dose collected with the second attempt was 1.1 × 106 CD34+ cells/kg (range 0–7.2). A third collection was attempted in six patients at median of 51 days (range 34–163) after the first failed mobilization. These patients collected a median of 1.1 × 106 CD34+ cells/kg (range 0–6.5). Total of 16 patients (67%) collected sufficient cells to undergo autologous stem cell transplant and eight patients (33%) were able to collect ≥2 × 106 CD34+ cells/kg in a single subsequent attempt. Our experience suggests that a majority of patients who fail primary mobilization despite use of P can collect sufficient HSC with a subsequent attempt using combination of G‐CSF with either P or GM‐CSF. J. Clin. Apheresis 29:293–298 2014. © 2014 Wiley Periodicals, Inc.
Keywords:plerixafor  G‐CSF  GM‐CSF  bone marrow harvest  autologous stem cell transplant
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号